Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Mélina Decourt"'
Autor:
Sarah Chevalier, Mélina Decourt, Maureen Francheteau, François Nicol, Anaïs Balbous, Pierre-Olivier Fernagut, Marianne Benoit-Marand
Publikováno v:
npj Parkinson's Disease, Vol 10, Iss 1, Pp 1-11 (2024)
Abstract Parkinson’s disease is characterized by the degeneration of substantia nigra pars compacta (SNc) dopaminergic neurons, leading to motor and cognitive symptoms. Numerous cellular and molecular adaptations following neurodegeneration or dopa
Externí odkaz:
https://doaj.org/article/90bd3bbde2cc4ab1a7edbdb46922720e
Autor:
Mélina Decourt, Eric Balado, Maureen Francheteau, Marcello Solinas, Marianne Benoît-Marand, Pierre-Olivier Fernagut
Publikováno v:
npj Parkinson's Disease, Vol 9, Iss 1, Pp 1-8 (2023)
Abstract Subtle cognitive impairment can occur early in the course of Parkinson’s disease (PD) and may manifest under different forms of executive dysfunction such as impaired cognitive flexibility. The precise contribution of nigrostriatal dopamin
Externí odkaz:
https://doaj.org/article/9d668e5e11c84054b68333eceb90fe76
A metabolic biomarker predicts Parkinson’s disease at the early stages in patients and animal models
Autor:
David Mallet, Thibault Dufourd, Mélina Decourt, Carole Carcenac, Paola Bossù, Laure Verlin, Pierre-Olivier Fernagut, Marianne Benoit-Marand, Gianfranco Spalletta, Emmanuel L. Barbier, Sebastien Carnicella, Véronique Sgambato, Florence Fauvelle, Sabrina Boulet
Publikováno v:
The Journal of Clinical Investigation, Vol 132, Iss 4 (2022)
Background Care management of Parkinson’s disease (PD) patients currently remains symptomatic, mainly because diagnosis relying on the expression of the cardinal motor symptoms is made too late. Earlier detection of PD therefore represents a key st
Externí odkaz:
https://doaj.org/article/09587078c22546ecb9d23f71bd52e432
Autor:
Mélina Decourt, Eric Balado, Haritz Jiménez-Urbieta, Maureen Francheteau, Pierre-Olivier Fernagut, Marianne Benoit-Marand
Publikováno v:
Biomedicines, Vol 10, Iss 3, p 542 (2022)
Treatment with dopamine agonists in Parkinson’s disease (PD) is associated with debilitating neuropsychiatric side-effects characterized by impulsive and compulsive behaviors. The vulnerability to develop such impairments is thought to involve inte
Externí odkaz:
https://doaj.org/article/a9259701ba1e4da7bef1f63fe9190b24
Publikováno v:
Biomedicines, Vol 9, Iss 6, p 684 (2021)
Parkinson’s disease (PD) is associated with a large burden of non-motor symptoms including olfactory and autonomic dysfunction, as well as neuropsychiatric (depression, anxiety, apathy) and cognitive disorders (executive dysfunctions, memory and le
Externí odkaz:
https://doaj.org/article/81d1198f7c9e45268cf4acf5d859cdf3
Autor:
Mélina Decourt, Eric Balado, Maureen Francheteau, Marcello Solinas, Marianne Benoît-Marand, Pierre-Olivier Fernagut
Subtle cognitive impairment can occur early in the course of Parkinson’s disease (PD) and may manifest under different forms of executive dysfunction such as impaired cognitive flexibility. The precise contribution of nigrostriatal dopaminergic neu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20ebc1cc5e91e9e03291d3e374207b12
https://doi.org/10.1101/2022.08.24.505066
https://doi.org/10.1101/2022.08.24.505066
Autor:
Mélina Decourt, Sebastien Carnicella, Marianne Benoit-Marand, Emmanuel L. Barbier, Gianfranco Spalletta, Sabrina Boulet, Laure Verlin, David Mallet, Carole Carcenac, Paola Bossù, Florence Fauvelle, Pierre-Olivier Fernagut, Véronique Sgambato, Thibault Dufourd
BackgroundCare management of Parkinson’s disease (PD) patients currently remains symptomatic, especially because diagnosis relying on the expression of the cardinal motor symptoms is made too late. Detecting PD earlier therefore represents a key st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d30687d6ef7275b62565ac72fec3837
https://doi.org/10.1101/2021.10.04.462993
https://doi.org/10.1101/2021.10.04.462993
A metabolic biomarker predicts Parkinson's disease at the early stages in patients and animal models
Autor:
David Mallet, Thibault Dufourd, Mélina Decourt, Carole Carcenac, Paola Bossù, Laure Verlin, Pierre-Olivier Fernagut, Marianne Benoit-Marand, Gianfranco Spalletta, Emmanuel L. Barbier, Sebastien Carnicella, Véronique Sgambato, Florence Fauvelle, Sabrina Boulet
Publikováno v:
The Journal of clinical investigation
The Journal of clinical investigation, 2022, 132 (4), pp.146400. ⟨10.1172/JCI146400⟩
The Journal of clinical investigation, 2022, 132 (4), pp.146400. ⟨10.1172/JCI146400⟩
International audience; BackgroundCare management of Parkinson's disease (PD) patients currently remains symptomatic, mainly because diagnosis relying on the expression of the cardinal motor symptoms is made too late. Earlier detection of PD therefor